Status:
COMPLETED
Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants
Lead Sponsor:
Papua New Guinea Institute of Medical Research
Collaborating Sponsors:
University of Melbourne
Case Western Reserve University
Conditions:
Malaria
Anemia
Eligibility:
All Genders
2-4 years
Phase:
NA
Brief Summary
In malaria-endemic areas, young children have an especially high risk of malaria morbidity and mortality. Malaria is estimated to cause up to 2 million deaths and 500 million clinical episodes in Afri...
Detailed Description
Intermittent preventive treatment in infancy (IPTi) is one of the most promising recent interventions to reduce the devastating impact of malaria in early childhood. Although two African studies have ...
Eligibility Criteria
Inclusion
- 3 months old living in the aera for the next 2 years, exlusive use of the study health facilities
Exclusion
- Known chronic illness, e.g. TB, diabetes, renal failure severe malnutrition (weight-for-age (WAZ) \< 60% percentile) severe anaemia (Hb \< 5 g/dl), or permanent disability, that prevents or impedes study participation
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT00285662
Start Date
June 1 2006
End Date
May 1 2010
Last Update
July 25 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Papua New Guinea Institute of Medical Research
Goroka, Papua New Guinea